Filing Details

Accession Number:
0001567619-19-007251
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-19 20:15:00
Reporting Period:
2019-03-15
Accepted Time:
2019-03-19 20:15:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197355 J Henry Fuchs C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
President, Worldwide R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-15 9,443 $94.53 133,061 No 4 F Direct
Common Stock Acquisiton 2019-03-15 12,840 $0.00 145,901 No 4 A Direct
Common Stock Disposition 2019-03-18 9,597 $94.09 136,304 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy Common Stock) Acquisiton 2019-03-15 32,160 $0.00 32,160 $94.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,160 2020-03-15 2029-03-14 No 4 A Direct
Footnotes
  1. Restricted stock units granted on March 15, 2019. Price not applicable.
  2. Trade made pursuant to a 10b5-1 plan executed on October 30, 2018.
  3. Option grant vests 12/48th on March 15, 2020 and 1/48th on the 15th day of each month thereafter.